Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Journal of Thoracic Disease|November 30, 2017
Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancerAlfredo Tartarone, Rosa Lerose, Maria Grazia Rodriquenz, et al.Future Oncology (London, England)|April 24, 2014
Long-term survival in small cell lung cancer: a case report and review of the literatureAlfredo Tartarone, Rosa Lerose, Raffaele Ardito, et al.Lung Cancer (Amsterdam, Netherlands)|July 2, 2013
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinibAlfredo Tartarone, Chiara Lazzari, Rosa Lerose, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 11, 2025
Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive moleculesCristina Filosa, Nicola Antonio Colabufo, Marcello Leopoldo, et al.Biomolecules|February 26, 2025
The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical ImplicationsRosalia Dieli, Rosa Lioy, Fabiana Crispo, et al.Leukemia Research|December 28, 2010
Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief reviewRoberto Guariglia, Maria Carmen Martorelli, Oreste Villani, et al.RSC Medicinal Chemistry|July 31, 2025
Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approachDomiziana Masci, Michela Puxeddu, Claudia Colla, et al.Archiv Der Pharmazie|August 21, 2023
Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer modelsCarmela Mazzoccoli, Fabiana Crispo, Ilaria Laurenzana, et al.Leukemia Research|November 26, 2009
Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromesPellegrino Musto, Oreste Villani, Maria Carmen Martorelli, et al.The International Journal of Biochemistry & Cell Biology|May 12, 2007
Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 proteinAlessandra Rosati, Massimo Ammirante, Antonio Gentilella, et al.Pageof 4